Released on = April 30, 2007, 5:18 am

Press Release Author = Bharat Book Bureau

Industry = Pharmaceuticals

Press Release Summary = The purpose of Developing Markets Series is to examine
prospects for the growth of pharmaceutical revenues in the developing economies of
Asia, Latin America and Eastern/Central Europe in three linked reports.

Press Release Body = The purpose of Developing Markets Series is to examine
prospects for the growth of pharmaceutical revenues in the developing economies of
Asia, Latin America and Eastern/Central Europe in three linked reports. Central and
Eastern European (CEE) Developing Markets for Pharmaceuticals, 2006-2011 - Part 3 of
Developing Markets - discusses prospects for the large developing market of Central
and Eastern Europe. The other reports discuss Asia and Latin America respectively.
Importantly, the growth of pharmaceutical markets in economically developing nations
has the potential to offset serious problems currently being experienced by the
global industry. The purpose of this report is to examine the prospects for the
growth of pharmaceutical revenues in the developing economies of Central and Eastern
Europe, at both regional and national level.

The growth of pharmaceutical markets in the developing nations has the potential to
offset serious problems currently experienced by the global industry. The principal
challenge is slow growth in North America, Western Europe and Japan.
In contrast, it predicts that all the leading developing markets will exhibit strong
growth from 2006-2011. Rapid economic growth and large, under-served populations
will drive that expansion. There will be significant growth in sales of both branded
and generic drugs through increasing demand from both public and private healthcare
sectors.

Central and Eastern European Developing Markets for Pharmaceuticals, 2006-2011,
examines developing pharmaceutical markets critically through comprehensive research
and analysis. It applied techniques such as financial forecasting, SWOT analyses and
discussion of qualitative factors. Societal, political, economic and commercial
issues are covered. The result is a comprehensive market-based report with detailed
analysis and informed opinion.

In particular, Central and Eastern European Developing Markets for Pharmaceuticals,
2006-2011, concentrates on the following themes :

A forecast of the global pharmaceutical market from 2006-2011, with key issues
discussed
Forecasts of sales revenues and growth rates for leading developing markets in
Central and Eastern Europe from 2006-2011
Drivers and opportunities in those markets
Restraints and threats in those markets
Discussion of key players and important therapeutic areas
Discussion of relevant regulatory, societal and economic issues
Comparison of the prospects for revenue generation in Asia, Latin America and
Central/Eastern Europe, with overall forecasts for those regions

Why you should buy this report :

To receive a comprehensive analysis of the prospects for developing regional and
national markets for pharmaceuticals in Central and Eastern Europe from 2006-2011,
as well as comparative data for other developing regions
To discover predicted revenues, growth rates and other key metrics for Central and
Eastern European developing markets from 2006-2011
To determine the forces that influence pharmaceutical sales in the Central and
Eastern European developing markets:
- Competitive characteristics of the market, both at national and regional level
- Regulatory, technological, societal and political issues
- Drivers and restraints
- Strengths, weaknesses, opportunities and threats

The dominant pharmaceutical markets of North America, Western Europe and Japan
currently account for approximately 85% of revenues for prescription drugs. However,
there is concern about the relatively low growth of those established markets in
recent years. Consequently, international pharmaceutical companies are very
interested in raising their profiles in the developing markets of Asia, Latin
America and Eastern/Central Europe.

Growth of the pharmaceutical markets in developing nations will clearly surpass that
of the established markets. That situation will provide one of the greatest
opportunities currently available to the international pharmaceutical industry. Many
developing countries have strongly growing economies; that factor constitutes a
driving force in the reform and broadening of healthcare systems. Improvements in
both the quality and reach of these healthcare provisions will drive the sales of
branded and generic products. Private healthcare will undergo similar developments.

Manufacturers of pharmaceuticals are currently working hard to address unmet
healthcare needs in developing countries. By doing so, they are making better
treatments available to millions of patients and improving the overall performance
of their companies.

For more information, Please visit : http://www.bharatbook.com/detail.asp?id

Web Site = http://www.bharatbook.com

Contact Details = Bharat Book Bureau
207, Hermes Atrium, Navi Mumbai - 400 614, India.
Ph. : +91-(022)-2757 8668 or +91-(022)-2757 9131
email : bharatbook@gmail.com